Alphatec Holdings, Inc. (ATEC): R&D Expense
$76.27M
Year ended 2025-12-31
$76.69M
Trailing 12 months to 2026-06-30
+20.1%
3-year compound annual growth
+32.4%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $76.27M | -5.5% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $80.72M | +15.1% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $70.11M | +59.2% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $44.03M | +37.5% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $32.02M | +70.8% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $18.75M | +35.4% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $13.85M | +40.6% | 2021-03-05, From 2019-01-01 |
| 2018-12-31 | $9.85M | n/c | 2020-03-17, From 2018-01-01 |
| 2017-12-31 | $4.92M | -46.8% | 2019-03-29, From 2017-01-01 |
| 2016-12-31 | $9.25M | -47.5% | 2018-03-09, From 2016-01-01 |
| 2015-12-31 | $17.61M | +6.2% | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | $16.59M | n/a | 2017-03-31, From 2014-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $76.27M | -5.5% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $84.61M | +18.4% |
| Orthofix Medical Inc. (OFIX) | 2025-12-31 | $65.85M | -10.6% |
| NovoCure Ltd (NVCR) | 2025-12-31 | $224.54M | +7.1% |
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $103.17M | -9.6% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $8.60M | -17.3% |
| Tandem Diabetes Care Inc (TNDM) | 2025-12-31 | $193.11M | -2.9% |
| Bioventus Inc. (BVS) | 2025-12-31 | $12.11M | -13.2% |
| Embecta Corp. (EMBC) | 2025-09-30 | $37.30M | -52.7% |
Compare ATEC, IRTC, OFIX, NVCR side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗